Gérard Jean Frantz Lambeau

Title: Gérard Jean Frantz Lambeau: Innovator in Nephrology

Introduction

Gérard Jean Frantz Lambeau is a notable inventor based in Cabris, France. He has made significant contributions to the field of nephrology, particularly through his innovative patent related to membranous nephropathy. His work has implications for the prognosis and monitoring of this condition, showcasing his expertise and dedication to medical research.

Latest Patents

Lambeau holds a patent titled "Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile and spreading." This patent discloses a method for assessing the prognosis of idiopathic membranous nephropathy using a body fluid sample from a human subject. The method involves profiling PLA2R1 epitopes recognized by autoantibodies in the sample. It also analyzes PLA2R1 epitope spreading among three PLA2R1 domains (Cys R, CTLD1, and CTLD7) recognized by anti-PLA2R1 autoantibodies. Notably, CTLD1 and CTLD7 are more closely associated with active idiopathic membranous nephropathy and are likely linked by a mechanism of epitope spreading.

Career Highlights

Throughout his career, Lambeau has worked with prestigious institutions, including Université de Nice Sophia Antipolis and Centre National de la Recherche Scientifique. His research has focused on understanding the complexities of nephrology and developing methods to improve patient outcomes.

Collaborations

Lambeau has collaborated with notable colleagues such as Vincent Louis Marie Esnault and Barbara Polski. These partnerships have contributed to the advancement of research in his field and have fostered a collaborative environment for innovation.

Conclusion

Gérard Jean Frantz Lambeau is a distinguished inventor whose work in nephrology has the potential to significantly impact patient care. His innovative patent on membranous nephropathy exemplifies his commitment to advancing medical science.